Filing Details
- Accession Number:
- 0001209191-14-024830
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-02 18:36:07
- Reporting Period:
- 2014-04-01
- Filing Date:
- 2014-04-02
- Accepted Time:
- 2014-04-02 18:36:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1562195 | Carl Lamm | 4698 Willow Road Pleasanton CA 94588 | Vp Of Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-04-01 | 482 | $1.25 | 25,106 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-01 | 482 | $19.83 | 24,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-04-01 | 534 | $10.20 | 25,158 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-01 | 534 | $19.83 | 24,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-04-01 | 366 | $11.30 | 24,990 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-01 | 366 | $19.83 | 24,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-04-01 | 625 | $4.30 | 25,249 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-01 | 625 | $19.83 | 24,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-04-01 | 283 | $1.43 | 24,907 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-01 | 283 | $19.83 | 24,624 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-01 | 482 | $0.00 | 482 | $1.25 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-01 | 534 | $0.00 | 534 | $10.20 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-01 | 366 | $0.00 | 366 | $11.30 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-01 | 625 | $0.00 | 625 | $4.30 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-01 | 283 | $0.00 | 283 | $1.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,930 | 2020-07-26 | No | 4 | M | Direct | |
| 8,532 | 2021-07-26 | No | 4 | M | Direct | |
| 8,406 | 2022-02-16 | No | 4 | M | Direct | |
| 20,000 | 2022-11-14 | No | 4 | M | Direct | |
| 2,271 | 2020-11-29 | No | 4 | M | Direct |
Footnotes
- The sales reported in this FORM 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 29, 2013 and amended on November 26, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- 25% of the granted 23,160 shares underlying this option became exercisable on 7/27/2011. The remaining vest in a series of 36 equal monthly installments provided the Reporting Person continues to provide services to ZELTIQ Aesthetics, Inc.
- 25% of the granted 25,862 shares underlying this option became exercisable on 7/27/2012, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer.
- One 48th of the granted 17,544 shares vest in equal monthly installments over a 48 month period from the grant date February 17, 2012, provided the Reporting Person continues to provide services to ZELTIQ Aesthetics, Inc.
- 25% of the granted 30,000 shares underlying this option became exercisable on 11/15/2013. The remaining vest in a series of 36 equal monthly installments provided the Reporting Person continues to provide services to ZELTIQ Aesthetics, Inc.
- 25% of the granted 13,623 shares underlying this option became exercisable on 11/30/2011. The remaining vest in a series of 36 equal monthly installments provided the Reporting Person continues to provide services to ZELTIQ Aesthetics, Inc.
Billionaire Hedge Funds
